Visual acuity poorly linked to GT after DSAEK

Article

Visual acuity poorly correlates to graft thickness (GT) in patients who underwent descemet stripping automated endothelial keratoplasty (DSAEK), states a paper in the journal Cornea.

Visual acuity poorly correlates to graft thickness (GT) in patients who underwent descemet stripping automated endothelial keratoplasty (DSAEK), states a paper in the journal Cornea.

Dr Maria Woodward et al., Department of Ophthalmology and Visual Sciences, University of Michigan, Ann Arbor, Michigan, USA, performed a retrospective chart review on 64 eyes of 52 patients who had anterior segment OCT imaging. The group obtained donor tissue characteristics and clinical information the eye bank and medical records, respectively.

Mean GT decreased from 199±45 μm to 165±53 μm , meaning there was a moderate correlation with preoperative and postoperative GT. Mean Snellen visual acuity was 20/28 at one year and 20/29 at the final follow up visit.

There was poor correlation between best-corrected visual acuity (BCVA) at the final visit and preoperative/postoperative GT. At the final follow up multivariate linear regression analysis demonstrated no relation of either postoperative GT or BCVA with donor tissue endothelial cell density, death-to-preservation time, death-to-surgery time, donor age, patient age or length of postoperative follow-up.

Please click here to read the abstract.

Recent Videos
Patrick C. Staropoli, MD, discusses clinical characterisation of Hexokinase 1 (HK1) mutations causing autosomal dominant pericentral retinitis pigmentosa
Richard B. Rosen, MD, discusses his ASRS presentation on illuminating subclinical sickle cell activities using dynamic OCT angiography
ASRS 2024: Socioeconomic barriers and visual outcomes in patients with rhegmatogenous retinal detachments, from Sally S. Ong, MD
Ashkan Abbey, MD, speaks about his presentation on the the CALM registry study, the 36-month outcomes of real world patients receiving fluocinolone acetonide 0.18 mg at the annual ASRS meeting in Stockholm, Sweden.
Nikoloz Labauri, MD, FVRS, speaks at the 2024 ASRS meeting about suspensory macular buckling as a novel technique for addressing myopic traction maculopathy
Jordana Fein, MD, MS, speaks with Modern Retina about the IOP outcomes with aflibercept 8 mg and 2 mg in patients with DME through week 48 of the phase 2/3 PHOTON trial at the annual ASRS meeting in Stockholm, Sweden.
John T. Thompson, MD, discusses his presentation at ASRS, Long-Term Results of Macular Hole Surgery With Long-Acting Gas Tamponade and Internal Limiting Membrane Peeling
ASRS 2024: Michael Singer, MD, shares 100-week results from the RESTORE trial
© 2024 MJH Life Sciences

All rights reserved.